ArticleFrontiers in immunology2021

Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients.

Peng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.